Antonella Sistigu

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli et al. · Nature Medicine · 2014 · 1K citations

Medicine, Cancer Biology, Oncology +12

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

Erika Vacchelli, Yuting Ma, Elisa Elena Baracco et al. · Science · 2015 · 437 citations

Medicine, Immunology, Oncology +13

An Immunosurveillance Mechanism Controls Cancer Cell Ploidy

Laura Senovilla, Ilio Vitale, Isabelle Martins et al. · Science · 2012 · 427 citations · Full text

Life Sciences, Immunology, Oncology +14

Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis

Giovanna Schiavoni, Antonella Sistigu, Mara Valentini et al. · Cancer Research · 2010 · 353 citations

Medicine, Immunology, Pharmacology +17

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists

Takahiro Yamazaki, Dalil Hannani, Vichnou Poirier-Colame et al. · Cell Death and Differentiation · 2013 · 245 citations · Full text

Medicine, Immunology, Oncology +12